Adma Biologics Inc

ADMANASDAQ · USD
8.95USD0.00 (+0.57%)
845

Adma Biologics Inc (ADMA) Options Open Interest

ADMA options open interest is 55,228 contracts. The 2-week average daily volume is 396 contracts across the chain.

Read more

Monitoring ADMA open interest helps you see where real money is positioned on Adma Biologics Inc's options and which strikes are attracting the most commitment from traders. Adma Biologics Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ADMA options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ADMA options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Adma Biologics Inc to settle.

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S.

pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ADMA open interest is concentrated. Our scanner maps Adma Biologics Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Adma Biologics Inc's options open interest as the signal it is, not as an afterthought.

2026-09-18
Calls
10.000.050.05141%+0.1229673
9.000.400.40183%+0.4901248
11.000.100.10260%+0.1350193
12.000.150.15369%+0.1449124
8.000.501.350.93111%+0.924996
Puts
9.000.100.650.38132%-0.5303249
8.000.050.05137%-0.117622
10.003.103.10994%-0.43291
11.001.603.802.70524%-0.65961
1.000.050.051,000%-0.00020

As of September 16, 2026

Follow the money

Track ADMA open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial